JPH058678B2 - - Google Patents
Info
- Publication number
- JPH058678B2 JPH058678B2 JP60143850A JP14385085A JPH058678B2 JP H058678 B2 JPH058678 B2 JP H058678B2 JP 60143850 A JP60143850 A JP 60143850A JP 14385085 A JP14385085 A JP 14385085A JP H058678 B2 JPH058678 B2 JP H058678B2
- Authority
- JP
- Japan
- Prior art keywords
- ferritin
- iron
- monoclonal antibody
- antibody
- serum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102000008857 Ferritin Human genes 0.000 claims description 106
- 108050000784 Ferritin Proteins 0.000 claims description 106
- 238000008416 Ferritin Methods 0.000 claims description 106
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 79
- 229910052742 iron Inorganic materials 0.000 claims description 40
- 230000003169 placental effect Effects 0.000 claims description 25
- 210000002966 serum Anatomy 0.000 claims description 25
- 230000009257 reactivity Effects 0.000 claims description 24
- 210000004185 liver Anatomy 0.000 claims description 13
- 210000002826 placenta Anatomy 0.000 claims description 8
- 230000002503 metabolic effect Effects 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- 230000002163 immunogen Effects 0.000 claims description 2
- 210000004923 pancreatic tissue Anatomy 0.000 claims description 2
- 239000000941 radioactive substance Substances 0.000 claims 1
- 238000000034 method Methods 0.000 description 19
- 210000001519 tissue Anatomy 0.000 description 19
- 210000004408 hybridoma Anatomy 0.000 description 13
- 210000004027 cell Anatomy 0.000 description 12
- 238000002965 ELISA Methods 0.000 description 10
- 102000004190 Enzymes Human genes 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 8
- 239000002953 phosphate buffered saline Substances 0.000 description 8
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 7
- 208000007502 anemia Diseases 0.000 description 7
- 238000003860 storage Methods 0.000 description 7
- 102000000546 Apoferritins Human genes 0.000 description 6
- 108010002084 Apoferritins Proteins 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- 238000003018 immunoassay Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 239000000427 antigen Substances 0.000 description 5
- 102000036639 antigens Human genes 0.000 description 5
- 108091007433 antigens Proteins 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 229940098773 bovine serum albumin Drugs 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 4
- 239000012980 RPMI-1640 medium Substances 0.000 description 4
- 208000019423 liver disease Diseases 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 3
- 206010003445 Ascites Diseases 0.000 description 3
- 206010065973 Iron Overload Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 229920001213 Polysorbate 20 Polymers 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 230000010438 iron metabolism Effects 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 102000013415 peroxidase activity proteins Human genes 0.000 description 3
- 108040007629 peroxidase activity proteins Proteins 0.000 description 3
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 3
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 3
- 238000003127 radioimmunoassay Methods 0.000 description 3
- 210000004988 splenocyte Anatomy 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- 206010035226 Plasma cell myeloma Diseases 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 230000007910 cell fusion Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- IMBKASBLAKCLEM-UHFFFAOYSA-L ferrous ammonium sulfate (anhydrous) Chemical group [NH4+].[NH4+].[Fe+2].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O IMBKASBLAKCLEM-UHFFFAOYSA-L 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 201000000050 myeloid neoplasm Diseases 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- 238000010517 secondary reaction Methods 0.000 description 2
- 239000007974 sodium acetate buffer Substances 0.000 description 2
- JVBXVOWTABLYPX-UHFFFAOYSA-L sodium dithionite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])=O JVBXVOWTABLYPX-UHFFFAOYSA-L 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 239000004971 Cross linker Substances 0.000 description 1
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 206010022971 Iron Deficiencies Diseases 0.000 description 1
- 102000008133 Iron-Binding Proteins Human genes 0.000 description 1
- 108010035210 Iron-Binding Proteins Proteins 0.000 description 1
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 208000016222 Pancreatic disease Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 208000031306 Rare hereditary hemochromatosis Diseases 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 241000473945 Theria <moth genus> Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- -1 acidophosphatase Proteins 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 231100000354 acute hepatitis Toxicity 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000031787 nutrient reservoir activity Effects 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 210000005059 placental tissue Anatomy 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- JLKDVMWYMMLWTI-UHFFFAOYSA-M potassium iodate Chemical compound [K+].[O-]I(=O)=O JLKDVMWYMMLWTI-UHFFFAOYSA-M 0.000 description 1
- 235000006666 potassium iodate Nutrition 0.000 description 1
- 239000001230 potassium iodate Substances 0.000 description 1
- 229940093930 potassium iodate Drugs 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60143850A JPS625999A (ja) | 1985-07-02 | 1985-07-02 | フエリチンに対する新規なモノクロ−ナル抗体 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60143850A JPS625999A (ja) | 1985-07-02 | 1985-07-02 | フエリチンに対する新規なモノクロ−ナル抗体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS625999A JPS625999A (ja) | 1987-01-12 |
| JPH058678B2 true JPH058678B2 (zh) | 1993-02-02 |
Family
ID=15348411
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP60143850A Granted JPS625999A (ja) | 1985-07-02 | 1985-07-02 | フエリチンに対する新規なモノクロ−ナル抗体 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS625999A (zh) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6212857A (ja) * | 1985-07-10 | 1987-01-21 | Green Cross Corp:The | 逆受身赤血球凝集反応用ヒトフエリチン測定試薬 |
| ES2303925T3 (es) * | 2004-08-12 | 2008-09-01 | F. Hoffmann-La Roche Ag | Metodo para diagnosticar la fibrosis hepatica. |
| CN111875696B (zh) * | 2020-08-17 | 2022-03-01 | 郑州伊美诺生物技术有限公司 | 一种纯化Ferr的方法 |
-
1985
- 1985-07-02 JP JP60143850A patent/JPS625999A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS625999A (ja) | 1987-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR0148619B1 (ko) | Pivka-x의 측정방법 및 측정시약 | |
| AU606605B2 (en) | Monoclonal antibodies to unreduced, nonenzymatically- glycated proteins | |
| Parker et al. | Hydrophobic binding sites on immunoglobulins | |
| JPH025893A (ja) | 新規抗体 | |
| JPH02503059A (ja) | 抗グリコシルアルブミンモノクロナル抗体とそれらの抗体を産生するハイブリッド細胞株、およびその使用 | |
| EP0384130A2 (en) | Myocardial infarction immunoassay | |
| JPH04503600A (ja) | 抗インターロイキン―１α及び―１βのモノクローナル抗体、その製法、ならびに前記抗体類の、インターロイキン―１α及び―１βの検出と治療への応用 | |
| KR20080106157A (ko) | Ｆａｓ 결합 항체 | |
| JP4431798B2 (ja) | 尿中のアネキシンｖの分析方法及びその利用 | |
| KR102189893B1 (ko) | bPAG1에 특이적으로 결합하는 항체 및 이의 용도 | |
| JP3018110B2 (ja) | モノクローナル抗体 | |
| KR910008637B1 (ko) | 심근 미오신 중사슬에 대한 단일클론항체 | |
| EP0479929B1 (en) | Vitamin b12 assay | |
| JPH1080272A (ja) | 雑種細胞系の使用方法 | |
| JPH058678B2 (zh) | ||
| JPWO2009044561A1 (ja) | 抗ｐｒｏＮＴ／ＮＭＮモノクローナル抗体 | |
| JP3076640B2 (ja) | ヒト９２ｋＤａゼラチナーゼの免疫学的定量法 | |
| JP2955082B2 (ja) | ヒトカルシトニンのｎ末端部分を特異的に認識するモノクローナル抗体 | |
| EP0575906A2 (en) | Sandwich immunoassay of beta-N-acetylglucosaminidase and monoclonal antibody used therein | |
| JPH0677017B2 (ja) | ヒト▲ｉｖ▼型コラーゲンのサンドイツチ酵素免疫学的定量法 | |
| JP5749643B2 (ja) | 診断及び予後の方法を実施するためのｉｒａｐタンパク質の使用 | |
| JP7313659B2 (ja) | 試料中のｈｍｇｂ１の測定方法及び測定試薬 | |
| JP2878317B2 (ja) | ラミニン測定試薬 | |
| KR101142418B1 (ko) | Ｒｏｍｏ1 단백질에 대한 항체, 이를 생산하는 하이브리도마 및 그 용도 | |
| JPS6373152A (ja) | エラスタ−ゼ１の免疫学的測定方法及び測定用試薬 |